Association of nitrosative and oxidative stress in young type 2 diabetic patients

Rasmita Padhy; Suvendu Sekhar Acharya; Nirupama Devi; S. Swain; Roma Rattan

doi:10.18203/2320-6012.ijrms20150816

Authors

Rasmita Padhy Department of Biochemistry, M.K.C.G Medical College, Berhampur, Odisha
Suvendu Sekhar Acharya Department of Biochemistry, M.K.C.G Medical College, Berhampur, Odisha
Nirupama Devi Department of Biochemistry, M.K.C.G Medical College, Berhampur, Odisha
S. Swain Department of Biochemistry, M.K.C.G Medical College, Berhampur, Odisha
Roma Rattan Dept. of Biochemistry SCB Medical College, Cuttack, Odisha

DOI:

https://doi.org/10.18203/2320-6012.ijrms20150816

Keywords:

Diabetes mellitus, Nitric oxide, Total oxidant load, Antioxidant capacity

Abstract

Background: Nitric oxide levels play an important role in the pathogenesis of endothelial dysfunction in type 2 diabetes mellitus (DM). Aim of the study was to assess the association between serum nitric oxide levels (NOx), Oxidant load (FOX2) and total antioxidant status (FRAP) with fasting blood sugar (FBS) in type 2 diabetic patients.

Methods: Serum concentration NOx was measured by Griess method in seventy six type 2 diabetic patients with age & sex matched (aged 45-65yrs) controls. Serum total oxidant load was estimated by Ferrous oxidation product in xylenol orange version 2 (FOX2), total antioxidant status by ferric reducing capacity of serum (FRAP) .FBS was estimated by commercial kits adapted to autoanalyser.

Results: Significant difference was observed in serum NO level between patients and controls (78.6+ 8.6 vs. 37.59+ 4.19μmol/L: p<0.000). Significantly high FOX 2 levels (12.4+ 2.6μmol/L vs. 4.33+ 1.7 μmol/L) and lower FRAPS level was observed in patients as compared to controls (61.37+31.64 μmol/L vs. 226.46+ 15.23 μmol/L).

Conclusions: Hyperglycemia leads to nitrosative stress (increase NO level) and oxidative stress by increasing total oxidant load (FOX2), decreasing antioxidant capacity (FRAP).

Metrics

Metrics Loading ...

References

Zhang Q, Malik P, de Chantemele EB, David JR. Fulton Arterioscler Thromb Vasc Biol. 2008;28:1627-33.

Huang, p.l,’eNOS, metabolic syndrome and cardiovascular disease. Trends Endocrinal Metabolism,2009.20(6):p.295-302.

Assunta Pandolfi, Natalia Di Pietro Europian society of cardiology: cardiovascular Research(2010)86,9-11doi:10

Williams SB, Goldfine AB, Timimi FK et al. acute hyperglycaemia attenuates endothelium dependent vasodilation in humans in vivo. Circulation 1998:97:1695-1701.

Pandolfi A, D Fulfo P et al. Increased vascular wall endothelial Nitric Oxide Synthase (eNOS) levels in umbilical cords from gestational diabetic women. Diabetologia 2005:48.

San Martin R, Sobrevia L. Gestational diabetes and adenosine/L-arginine/nitric oxide (ALANO) pathway in human umbilical vein endothelium. Placenta 2006:27:1-10.

Guugliano D, Ceriello A Diabetes mellitus, hypertension and cardiovascular disease: which role for oxidative stress? Metabolism 44:363-368.

Tesfamariam B 1994 Free radicals in diabetic endothelial cell dysfunction. FreevRadic Bio Med 16:383-391.

Sowers JR. Hypertension, angiotensin II and oxidative stress. N Engl J Med 2002; 346:1999–2001.

Bedrad K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev. 2007;87:245–313.

Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007;87:315–424.

Zhang DX, Gutterman DD. Mitochondrial reactive oxygen species-mediated signaling in endothelial cells. Am J Physiol Heart Circ Physiol. 2007;292:H2023–H2031.

Yang P, Zhao Z, Reece EA. Activation of oxidative stress signaling that is implicated in apoptosis with a mouse model of Diabetic embryopathy. Biochem Biophys Res Commun. 2007;357:749-54.

Pubela C, Farias M, Gonzaiez M, Vecchiola A, Krause B et al. High D-glucose reduces SLC29A1 promoter activity and adenosine transport involving specific protein 1 in human umbilical vein endothelium. J Cell Physiol. 2008;215:645-56.